The cytokine IL-1 mediates diverse forms of neurodegeneration, but its mechanism of action is unknown. We have demonstrated previously that exogenous and endogenous IL-1 acts specifically in the rat striatum to dramatically enhance ischemic and excitotoxic brain damage and cause extensive cortical injury. Here we tested the hypothesis that this distant effect of IL-1 is mediated through polysynaptic striatal outputs to the cortex via the hypothalamus. We show that IL-1 injected into the rat striatum with the excitotoxin ␣-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (S-AMPA) caused increased expression of IL-1 (mRNA and protein) mainly in the cortex where maximum injury occurs. Marked increases in IL-1 mRNA and protein were also observed in the hypothalamus. S-AMPA, injected alone into the striatum, caused only localized damage, but administration of IL-1 into either the striatum or the lateral hypothalamus immediately after striatal S-AMPA resulted in widespread cell loss throughout the ipsilateral cortex. Finally we showed that the cortical cell death produced by striatal coinjection of S-AMPA and IL-1 was significantly reduced by administration of the IL-1 receptor antagonist into the lateral hypothalamus. These data suggest that IL-1 can act in the hypothalamus to modify cell viability in the cortex. We conclude that IL-1-dependent pathways project from the striatum to the cortex via the hypothalamus and lead to cortical injury, and that these may contribute to a number of human neurological conditions including stroke and head trauma. E xcessive activation of glutamate receptors (excitotoxicity) contributes to a number of neurodegenerative disorders (1). Thus direct injection of glutamatergic agonists into the brains of experimental animals has proved a useful model to study, in vivo, the underlying mechanisms of cell death in such acute conditions. There is increasing interest in the role of inflammatory mediators such as IL-1 in cell death in this and other forms of neurodegeneration, such as cerebral ischemia (2).The cytokine IL-1 has diverse actions in the brain and mediates acute experimental neurodegeneration (3). Injection or overexpression of IL-1 receptor antagonist (IL-1ra) significantly inhibits neuronal damage induced in rodents by focal cerebral ischemia, traumatic brain injury, or excitotoxin administration (see ref.2). Administration of exogenous IL-1 fails to cause neuronal death in normal rat brain but markedly exacerbates ischemic, traumatic, or excitotoxic brain injury (4-6). When IL-1 is coinjected with ␣-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (S-AMPA) in the rat striatum, extensive cell death occurs throughout the ipsilateral cortex, which is not observed after S-AMPA alone (6). The mechanism of this potent effect of IL-1 is not known, although in focal cerebral ischemia, exacerbation by IL-1 and neuroprotective actions of IL-1ra are also mediated through actions in the striatum that influence cortical damage (7). Because excitotoxicity contributes to many forms of n...